Episode 9: The Hematopathology Team: from Slide to Strategy
Commercial Strategy Optimization
Oncology & Hematology
Pre-launch
Summary
In episode 9, we are joined by Dr. Philip Kuriakose and Dr. Juan Gomez-Gelvez, who analyse how collaboration within hematopathology drives optimal patient care.
-
Dr. Philip Kuriakose, MD is a Hematology Medical Oncologist and the Medical Director of the Hemophilia and Thrombosis Treatment Center at Henry Ford Health.
-
Dr. Juan Gomez-Gelvez, MD is a Hematopathologist, Molecular Pathologist and the Section Head of Molecular Hematopathology also at Henry Ford Health.
The Better Testing, Better Treatment Podcast
Transcript
Sign up to our newsletter
Sign up to our bi-weekly newsletter covering the latest insights to optimize commercialization of diagnostic driven therapies to help empower your decisions.
READY TO DO COMMERCIALIZATION DIFFERENTLY?
Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find them so more people get the right therapy sooner.
You might also be interested in?
Rethinking Drug Commercialization: Navigating a Shifting Biotech Investment Landscape
Explore strategies for biotech commercialization amid evolving investment landscapes, focusing on precision and rare disease therapies. Join industry experts in navigating funding challenges and enhancing patient outcomes.
Commercial Strategy Optimization